Alerts will be sent to your verified email
Verify Email
SHIVALIK
|
Shivalik Rasayan
|
Bharat Parenterals
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Chemical Sector
|
|||
|
Capacity Utilization - Dimethoate
|
95.0 % | n/a | n/a |
|
Realization/Tonne - Dimethoate
|
299080.92 Rs/MT | n/a | n/a |
|
Realization/Tonne - Sodium hydrosulfide
|
4487.46 Rs/MT | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
7.33 % | 12.73 % | 9.28 % |
|
5yr average Equity Multiplier
|
1.84 | 1.76 | 1.75 |
|
5yr Average Asset Turnover Ratio
|
0.47 | 0.86 | 0.5 |
|
5yr Avg Net Profit Margin
|
8.37 % | 8.73 % | 10.38 % |
|
Price to Book
|
1.55 | 2.35 | 2.72 |
|
P/E
|
49.88 | 0.0 | 44.4 |
|
5yr Avg Cash Conversion Cycle
|
79.22 Days | 122.06 Days | -14.29 Days |
|
Inventory Days
|
63.09 Days | 46.56 Days | 46.75 Days |
|
Days Receivable
|
114.67 Days | 179.99 Days | 51.16 Days |
|
Days Payable
|
157.87 Days | 95.97 Days | 103.34 Days |
|
5yr Average Interest Coverage Ratio
|
10.93 | 22.68 | 5.43 |
|
5yr Avg ROCE
|
9.58 % | 16.02 % | 10.08 % |
|
5yr Avg Operating Profit Margin
|
18.09 % | 11.16 % | 24.06 % |
|
5 yr average Debt to Equity
|
0.16 | 0.26 | 0.47 |
|
5yr CAGR Net Profit
|
-1.91 % | -9.67 % | 3.94 % |
|
5yr Average Return on Assets
|
3.97 % | 8.0 % | 5.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
47.37 % | 67.2 % | 53.58 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.95 % | -6.64 % | -13.96 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shivalik Rasayan
|
Bharat Parenterals
|
Sakar Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|